IL6 and COVID-19: Summing up, our findings provide compelling evidence for the dynamic interplay of critical immune components during COVID-19 recovery, emphasizing the potential role of IL-6 and purinergic signaling regulatory effects that could influence the inhibition of disease progression and concomitant patient recovery.